We Can’t Trust Palantir with Our NHS Data

Why It Matters

Entrusting sensitive health data to a firm linked to controversial security operations threatens privacy, democratic oversight, and public confidence in the NHS’s stewardship of taxpayer money.

Key Takeaways

• Palantir secured NHS data contract worth $15bn over two years
• Private firms earned $2bn profit from NHS contracts, sparking backlash
• Company linked to Israeli defence and US ICE immigration enforcement
• Palantir paid no US federal income tax in 2025 despite large contracts
• Critics call for replacing Palantir with more trustworthy data partners

Pulse Analysis

Palantir’s foothold in the UK’s National Health Service illustrates a broader trend of governments outsourcing critical data functions to private tech firms. The NHS contract, initially justified by promises of accelerated cancer diagnostics and streamlined patient flow, is part of a $15 billion procurement wave that has already generated roughly $2 billion in private‑sector profit. While the partnership touts operational efficiency, it also exposes the health system to a vendor whose core clientele includes defence ministries and immigration enforcement agencies, raising questions about data sovereignty and ethical alignment.

The controversy deepens when Palantir’s global activities are examined. Its strategic partnership with Israel’s defence industry and longstanding work with the US Immigration and Customs Enforcement agency have drawn fire from civil‑rights groups and lawmakers concerned about surveillance and racial bias. Adding to the outcry, investigative reports show the company avoided paying any US federal income tax in 2025, despite securing hundreds of millions in public contracts. Such fiscal opacity fuels public distrust, especially when taxpayer money funds a firm perceived as prioritising profit over public interest.

For policymakers, the Palantir episode may serve as a catalyst for stricter procurement standards and greater scrutiny of vendor ethics. Alternatives—home‑grown platforms or European firms with stronger data‑privacy frameworks—are gaining attention as viable replacements. As the UK debates the balance between digital innovation and democratic accountability, the outcome will likely shape how public institutions safeguard sensitive information while meeting efficiency goals.